
Santhera enters license agreement with Chiesi Group; Tonix's cocaine intoxication drug, Iovance's cervical cancer treatment win FDA's breakthrough status
→ Swiss-based Santhera has entered an exclusive global — except for the US and Canada— license agreement with international research-focused healthcare group Chiesi Farmaceutici. The …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.